Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes - Samuelson Bannow, B T; Walter, R B; Gernsheimer, T B; Garcia, D A (J Thromb Thrombolysis, 2017)